Penile Cancer Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Conditions: Acinar Cell Carcinoma; Adrenal Cortex Carcinoma; Adrenal Gland Pheochromocytoma; Anal Canal Neuroendocrine Carcinoma; Anal Canal Undifferentiated Carcinoma; Appendix Mucinous Adenocarcinoma; Bladder Adenocarcinoma; Bronchioloalveolar Carcinoma; Cervical Adenocarcinoma; Cervical Squamous Cell Carcinoma, Not Otherwise Specified; Cholangiocarcinoma; Chordoma; Colorectal Squamous Cell Carcinoma; Endometrial Adenocarcinoma; Endometrioid Adenocarcinoma; Esophageal Neuroendocrine Carcinoma; Esophageal Undifferentiated Carcinoma; Extrahepa...
Source: ClinicalTrials.gov - July 13, 2016 Category: Research Source Type: clinical trials

Trial of Pembrolizumab for Advanced Penile Squamous Cell Carcinoma
 Condition : Penile Squamous Cell Carcinoma Intervention : Drug: Pembrolizumab Sponsors : University of Alabama at Birmingham; Merck Sharp & Dohme Corp. Not yet recruiting - verified June 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 1, 2016 Category: Research Source Type: clinical trials

Trial of Pembrolizumab for Advanced Penile Squamous Cell Carcinoma
Condition: Penile Squamous Cell CarcinomaIntervention: Drug: PembrolizumabSponsors: University of Alabama at Birmingham; Merck Sharp & Dohme Corp.Not yet recruiting - verified June 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 1, 2016 Category: Research Source Type: clinical trials